@johndprent has already used this argument of small patients compared to the potential cancer market but he didn't know the treatment cost is so expensive for the current treatment of DLBCL which is usually the case for treatment of rare cancer, this also applies to Cholangiocarcinoma.
IMU Price at posting:
4.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)